Vivanza Biosciences Quarterly Results for Trading Insights
VIVANZA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QSept 2025
Vivanza Biosciences Quarterly Results Key Highlights
- Revenue of ₹55 Cr in Sept 2025 (+5400.0% vs Mar 2025, +1733.3% vs Sept 2024)
- Net Profit of ₹1 Cr in Sept 2025 (+200.0% vs Mar 2025)
- EBITDA of ₹1 Cr in Sept 2025 (+200.0% vs Mar 2025)
- Operating Margin of 1.0% in Sept 2025 (+201.0pp vs Mar 2025)
- Earnings Per Share of ₹0.14 in Sept 2025 (+156.0% vs Mar 2025)
Vivanza Biosciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 55 | 1 | 9 | 3 | 4 | 5400.0% | 1733.3% |
| Net Profit (₹ Cr) | 1 | -1 | 0 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 1 | -1 | 0 | 0 | 0 | - | - |
| EPS (₹) | 0.14 | -0.25 | 0.02 | 0.00 | -0.10 | - | - |
| Operating Margin (%) | 1.0% | -200.0% | 2.0% | 4.0% | -3.0% | - | - |
Vivanza Biosciences Share Price Trend Around Quarterly Results
Visualize Vivanza Biosciences's 1-year price movement across quarterly results — ideal for logging trades in Vivanza Biosciences share price
chart using Tickjournal. All values in ₹.
Related Pages for Vivanza Biosciences
Additional stock information and data for VIVANZA
Revenue Trend (₹ Cr)
Sept 2024
3
Jun 2025
9
Mar 2025
1
Sept 2025
55
Net Profit Trend (₹ Cr)
Sept 2024
0
Jun 2025
0
Mar 2025
-1
Sept 2025
1
Operating Margin Trend (%)
Sept 2024
4.0%
Jun 2025
2.0%
Mar 2025
-200.0%
Sept 2025
1.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Vivanza Biosciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1752.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.8 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6403.5 | 2,860 | 689 | +7.1% | - | 24.1% | 246.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4369.2 | 3,219 | 591 | +11.3% | - | 18.4% | 249.1 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1351.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.8 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1294.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.0 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores